BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12570832)

  • 1. Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.
    Cohen Y; Polliack A; Nagler A
    Curr Pharm Des; 2003; 9(3):279-88. PubMed ID: 12570832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of refractory autoimmune diseases with ablative immunotherapy.
    Cohen Y; Nagler A
    Autoimmun Rev; 2004 Feb; 3(2):21-9. PubMed ID: 15003184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
    Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice].
    Kozák T; Becvár R; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
    Cas Lek Cesk; 2000 Jun; 139(11):329-33. PubMed ID: 10953411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review.
    Openshaw H; Nash RA; McSweeney PA
    Biol Blood Marrow Transplant; 2002; 8(5):233-48. PubMed ID: 12064360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapies for systemic sclerosis.
    Cipriani P; Ruscitti P; Giacomelli R
    Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
    Pers YM; Jorgensen C
    Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
    Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases.
    Kozák T; Rychlík I
    Isr Med Assoc J; 2002 Apr; 4(4):268-71. PubMed ID: 12001701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High dose chemotherapy procedures supported by hemopoietic stem cell transplantation in treatment of autoimmune diseases].
    Skotnicki AB; Wójcik MA
    Pol Arch Med Wewn; 2001; 105 Suppl():167-71. PubMed ID: 12412243
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
    Cohen Y; Nagler A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162
    [No Abstract]   [Full Text] [Related]  

  • 15. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction.
    Tyndall A; Koike T
    Intern Med; 2002 Aug; 41(8):608-12. PubMed ID: 12211526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation in rheumatoid arthritis.
    Snowden JA; Kapoor S; Wilson AG
    Autoimmunity; 2008 Dec; 41(8):625-31. PubMed ID: 18958746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation.
    Van Bekkum DW
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S37-9. PubMed ID: 12931239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.